10 deaths reported following use of newly marketed diabetes drugs (Japan)

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
Ten people suffering from diabetes mellitus died after taking a new class of medications that have been on the market since last April, according to an Asahi Shimbun analysis.

Although an association between the fatalities and the drugs has yet to be confirmed, the health ministry plans to call on manufacturers to revise their package inserts to alert users on the proper use of the medicines.

More than 100,000 people are now estimated to be using the drugs across the country.

The six new drugs belong to a class of medications known as sodium-glucose cotransporter 2 (SGLT2) inhibitors. They target patients with Type 2 diabetes, the most common type of diabetes mellitus in Japan. The disease is typically seen in those who live unhealthy lifestyles.

http://ajw.asahi.com/article/behind_news/social_affairs/AJ201501090058
 
Status
Not open for further replies.
Back
Top